MycoMedica Life Sciences
MycoMedica Life Sciences is a Healthcare & Life Sciences startup based in Shelton, the United States, most recent round Series C+, 2 tracked investors.
About MycoMedica Life Sciences
MycoMedica Life Sciences is a startup founded in 2021 based in Shelton, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based psychedelic medicines for mental health and neurodegenerative disorders, focusing on clinical trials for conditions such as Premenstrual Dysphoric Disorder, OCD, and Parkinson's Disease.
Explore MycoMedica Life Sciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.